Upload
reilly-levick
View
219
Download
1
Embed Size (px)
Citation preview
‘‘Direct to Direct to Pharmacy’Pharmacy’
David WatsonDavid Watson
Trade DirectorTrade Director
Pfizer LtdPfizer Ltd
HeadlinesHeadlines
We’ll boycott Pfizer brands, warn contractorsC&D 7 October 2006
We’ll boycott Pfizer brands, warn contractorsC&D 7 October 2006
This is a bad move for PharmacistsSteve Dunn , C&D 7 October 2006
This is a bad move for PharmacistsSteve Dunn , C&D 7 October 2006
Public scrutiny will exonerate PfizerThe Times October 2006
Public scrutiny will exonerate PfizerThe Times October 2006
Pfizer upsetting the apple cartPharma Times November 2006
Pfizer upsetting the apple cartPharma Times November 2006
Supply chain control
Supply chain control
Changing portfolio
Changing portfolio
Power of wholesalers
Power of wholesalers
Integrity ofsupply
Integrity ofsupply
Patientsafety
Patientsafety
Pharmacycustomer
Pharmacycustomer
Why the change?Why the change?
All UK wholesalers with national coverage were invited to participate in negotiations – RFP
After intensive discussions and a comprehensive due diligence programme, Unichem were appointed as an LSP on an initially exclusive basis
After initial AAH agreement to heads of terms, AAH withdrew in January 2006, notified to Pfizer by Celesio Headquarters
Appointment processAppointment process
Pharmacists can buy Pfizer products directly from Pfizer, ownership and visibility of Pfizer products remains with Pfizer until sale to the pharmacist
Pfizer has appointed UniChem as a Logistics Service Provider (LSP) to carry out a full range of services on behalf of Pfizer, for which Pfizer will pay UniChem a fee per pack
Pfizer does not sell Pfizer products to Unichem or to any other wholesaler, Unichem does not act as a wholesaler in relation to UK sourced Pfizer products
Pricing and discounting on Pfizer products the responsibility of Pfizer
How does DTP workHow does DTP work
you’re forcing me to buy from UniChem…
you’re forcing me to buy from UniChem…
You can’t cover the
whole of the UK
You can’t cover the
whole of the UK
You can’t dictate your own discount
scheme
You can’t dictate your own discount
scheme
UniChem don’t have
the capacity
UniChem don’t have
the capacity
UniChem will preferably
supply Boots
UniChem will preferably
supply Boots
ChallengesChallenges
What if UniChem
go on strike
What if UniChem
go on strike
My mailboxMy mailbox
Key metrics: 97% of all ‘dispensing points’ in the UK have
ordered products from Pfizer 6.9 million units have been delivered 99.7% ‘on time, in full’ delivery accuracy
First 3 monthsFirst 3 months
Pfizer has the ability to through DTP to develop a new pharmacy commercial value proposition and service approach
UK Pharmacy has an emerging role in the management of patient treatment through the new Pharmacy contract
Changes in Pfizer portfolio in the next few years mean pharmacy purchasing choice becomes a more important factor in the growth of many Pfizer products
Pfizer are developing a number of customer facing strategies to support our wide portfolio, and provide additional services to pharmacy
Commercial OpportunityCommercial Opportunity
OFT short term studyOFT short term study
Market study – not a review specifically on Pfizer Many different (and conflicting) interests and opinions
have been heard Market practices on discounting arrangements in the UK
are not transparent Evolution of the pharmaceutical distribution market
difficult to predict
What happens nextWhat happens next
Other Pharma Co’s may make similar changes (AZ, Lilly, Sanofi Aventis)
Some may focus on Hospital distribution rather than the entire community pharmacy customer base
Wholesaler business impact depends on market change over time – not simply Pfizer move
Wholesalers willingness to embrace change and compete effectively against new entrants in sector?
Pharma Industry increasingly focusing on the role of the Pharmacist in provision of healthcare
[email protected]@pfizer.com